In the study of Jeong et al. [11] the multivariate analysis showed that CD44 expression was an independent risk factor predicting recurrence-free survival, disease-specific survival, and overall survival in patients with ccRCC. The gene discussed is CD44; the disease is nonpapillary renal cell carcinoma.